Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effectiveness of Cryotherapy on the Fatigue of Patients With Multiple Sclerosis

NCT: NCT05219201 · COMPLETED

NCT IDNCT05219201
StatusCOMPLETED
Start Date2022-09-12
Completion2025-07-11

Brief Summary

the aim of the study is to evaluate the effectiveness of partial-body cryotherapy (PBC) on the symptoms of patients with multiple sclerosis during a rehabilitation stay.

Frequently Asked Questions

What is Effectiveness of Cryotherapy on the Fatigue of Patients With Multiple Sclerosis?

Effectiveness of Cryotherapy on the Fatigue of Patients With Multiple Sclerosis is a clinical trial registered under NCT05219201. Current status: COMPLETED.

What is the status of NCT05219201?

The current status of NCT05219201 (Effectiveness of Cryotherapy on the Fatigue of Patients With Multiple Sclerosis) is: COMPLETED.

When did Effectiveness of Cryotherapy on the Fatigue of Patients With Multiple Sclerosis start?

Effectiveness of Cryotherapy on the Fatigue of Patients With Multiple Sclerosis started on 2022-09-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑